Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Esketamine is J&J's patented version of ketamine, a dissociative anesthetic with psychedelic properties that was first synthesized in 1962. Numerous scientific studies have demonstrated ketamine's ...

Yesterday, the drugmaker added to the evidence behind Spravato – an intranasal formulation of esketamine – with the release of top-line data from a head-to-head study with a long-acting ...

Esketamine, the S isomer of ketamine, has already gained approval for treatment-resistant depression under the trademark Spravato; psilocybin and ketamine have been shown to provide benefits to ...

The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent version of ketamine. Esketamine should only provide rapid relief from depression symptoms until other ...

Rao cited Johnson & Johnson's Spravato (esketamine), a hallucinogen drug closely related to ketamine, as an example of a therapy the FDA has approved that has mood-altering properties. Esketamine ...

Intraoperative esketamine infusion significantly reduced the incidence of postpartum depression (PPD) at 6 weeks post partum in women undergoing cesarean delivery. Evidence Rating Level: 1 (Excellent) ...

The Daily Gate mobile app brings you the latest local breaking news, updates, and more. Read the Daily Gate on your mobile device just as it appears in print.

I provide outpatient psychiatric evaluations, medication management, supportive therapy, (GeneSight) pharmacogenomic testing, and Esketamine/Spravato treatments. Promoting a safe environment for ...

I have expertise in interventional psychiatric approaches including esketamine and TMS therapy. I believe in building a strong relationship to work towards a common goal of mental wellness.